Birchcreek Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
674
-6
-0.9% -$2.14K 0.11% 108
2025
Q4
$223K Sell
680
-165
-20% -$52.3K 0.11% 109
2025
Q3
$238K Sell
845
-101
-11% -$29.3K 0.12% 105
2025
Q2
$264K Sell
946
-148
-14% -$41.9K 0.15% 93
2025
Q1
$341K Sell
1,094
-167
-13% -$49.3K 0.22% 85
2024
Q4
$329K Buy
1,261
+362
+40% +$107K 0.21% 93
2024
Q3
$290K Buy
899
+57
+7% +$18.6K 0.19% 92
2024
Q2
$263K Buy
842
+28
+3% +$8.23K 0.15% 123
2024
Q1
$231K Buy
+814
New +$238K 0.12% 139

Other funds holding AMGN

Birchcreek Wealth Management's AMGN Position: Q1 2026 in Review

Birchcreek Wealth Management reduced its Amgen (AMGN) stake by 0.88% in Q1 2026, selling an estimated $2.14K and leaving 674 shares worth $237K. The position accounts for 0.11% of the portfolio, ranked #108.

Birchcreek Wealth Management first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $341K in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Birchcreek Wealth Management held 674 shares of Amgen worth $237K as of Q1 2026.
  • Birchcreek Wealth Management sold 6 Amgen shares in Q1 2026, an estimated $2.14K.
  • Amgen made up 0.11% of Birchcreek Wealth Management's portfolio in Q1 2026, its #108 holding.
  • Birchcreek Wealth Management first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • Birchcreek Wealth Management's Amgen position peaked at $341K in Q1 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Birchcreek Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.